{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:54:49Z","timestamp":1773273289938,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":5515,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1006\/mthe.2001.0449","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T15:46:30Z","timestamp":1032363990000},"page":"217-222","source":"Crossref","is-referenced-by-count":99,"title":["Sustained and Complete Phenotype Correction of Hemophilia B Mice Following Intramuscular Injection of AAV1 Serotype Vectors"],"prefix":"10.1016","volume":"4","author":[{"given":"Hengjun","family":"Chao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Monahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.Jude","family":"Samulski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher E.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/mthe.2001.0449_bib1","unstructured":"Roberts, H., and Hoffman, M.1995. Hemophilia and related conditions\u2014inherited deficiencies of prothrombin(factor II), factor V, and factor VII to XII. In Williams HematologyE. Beutler, et al., Eds., pp. 1415\u20131416. McGraw-Hill, Inc. New York."},{"key":"10.1006\/mthe.2001.0449_bib2","unstructured":"Roberts, H., and Lozier, J.1991. Clinical aspects and therapy for hemophilia B. In Hematology, Basic Principles and PracticeR. Hoffman, et al., Eds., pp. 1325\u20131331. Churchill-Livingstone, New York."},{"key":"10.1006\/mthe.2001.0449_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2796.1997.130135000.x","article-title":"Haemophilia prophylaxis in young patients\u2014a long-term follow-up","volume":"241","author":"Lofqvist","year":"1997","journal-title":"J. Intern. Med."},{"key":"10.1006\/mthe.2001.0449_bib4","first-page":"131","article-title":"Adeno-associated viral vectors","author":"Samulski","year":"1999","journal-title":"The Development of Human Gene Therapy."},{"key":"10.1006\/mthe.2001.0449_bib5","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/sj.gt.3301024","article-title":"Persistent expression of canine factor IX in hemophilia B canines","volume":"6","author":"Chao","year":"1999","journal-title":"Gene Ther."},{"key":"10.1006\/mthe.2001.0449_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/4743","article-title":"Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector","volume":"5","author":"Herzog","year":"1999","journal-title":"Nat. Med."},{"key":"10.1006\/mthe.2001.0449_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/73464","article-title":"Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector","volume":"24","author":"Kay","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1006\/mthe.2001.0449_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/mthe.2000.0219","article-title":"Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors","volume":"2","author":"Chao","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1006\/mthe.2001.0449_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/10430340050015716","article-title":"The use of adeno-associated virus to circumvent the maturationdependent viral transduction of muscle fibers","volume":"11","author":"Pruchnic","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2001.0449_bib10","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood.V90.10.3962","article-title":"A coagulation factor IX-deficient mouse model for human hemophilia B","volume":"90","author":"Lin","year":"1997","journal-title":"Blood."},{"key":"10.1006\/mthe.2001.0449_bib11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood.V91.3.784","article-title":"Human factor IX corrects the bleeding diathesis of mice with hemophilia B","volume":"91","author":"Kung","year":"1998","journal-title":"Blood."},{"key":"10.1006\/mthe.2001.0449_bib12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0037-1615666","article-title":"A tail vein bleeding time model and delayed bleeding in hemophiliac mice","volume":"85","author":"Broze","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1006\/mthe.2001.0449_bib13","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood.V97.5.1258","article-title":"Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA","volume":"97","author":"Nathwani","year":"2001","journal-title":"Blood."},{"key":"10.1006\/mthe.2001.0449_bib14","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.94.11.5804","article-title":"Stable gene transfer and expression of human coagulation factor IX after intramuscular injection of recombinant adeno-associated virus","volume":"94","author":"Herzog","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1006\/mthe.2001.0449_bib15","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood.V97.12.3733","article-title":"Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX","volume":"97","author":"Ge","year":"2001","journal-title":"Blood."},{"key":"10.1006\/mthe.2001.0449_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0171-2985(96)80033-7","article-title":"Cyclophosphamide-induced immunological tolerance: an overview","volume":"195","author":"Mayumi","year":"1996","journal-title":"Immunobiology."},{"key":"10.1006\/mthe.2001.0449_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000462137","article-title":"The treatment of factor VIII inhibitors\u2014a general overview","volume":"70","author":"White","year":"1996","journal-title":"Vox Sang."},{"key":"10.1006\/mthe.2001.0449_bib18","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1128\/JVI.74.6.2777-2785.2000","article-title":"Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors","volume":"74","author":"Bartlett","year":"2000","journal-title":"J. Virol."},{"key":"10.1006\/mthe.2001.0449_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/clim.1999.4724","article-title":"Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration","volume":"92","author":"Brockstedt","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1006\/mthe.2001.0449_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/mthe.2000.0032","article-title":"Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX","volume":"1","author":"Fields","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1006\/mthe.2001.0449_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/mthe.2000.0045","article-title":"Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors","volume":"1","author":"Xiao","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1006\/mthe.2001.0449_bib22","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1073\/pnas.96.7.3906","article-title":"Sustained correction of bleeding disorder in hemophilia B mice by gene therapy","volume":"96","author":"Wang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1006\/mthe.2001.0449_bib23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ng0797-270","article-title":"Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors","volume":"16","author":"Snyder","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1006\/mthe.2001.0449_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0049-3848(84)90257-3","article-title":"Factor VIII inhibitor treatment with high doses of F VIII","volume":"34","author":"Stenbjerg","year":"1984","journal-title":"Thromb. Res."},{"key":"10.1006\/mthe.2001.0449_bib25","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood.V91.9.3273","article-title":"Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy","volume":"91","author":"Connelly","year":"1998","journal-title":"Blood."},{"key":"10.1006\/mthe.2001.0449_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/JVI.75.1.269-277.2001","article-title":"Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors","volume":"75","author":"Sarukhan","year":"2001","journal-title":"J. Virol."},{"key":"10.1006\/mthe.2001.0449_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.immunol.19.1.47","article-title":"Cross-presentation, dendritic cells, tolerance and immunity","volume":"19","author":"Heath","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1006\/mthe.2001.0449_bib28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1084\/jem.188.2.409","article-title":"Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction","volume":"188","author":"Kurts","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1006\/mthe.2001.0449_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1006\/mthe.2001.0449_bib30","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V95.5.1594.005k34_1594_1599","article-title":"Sustained expression of human factor VIII in mice using a parvovirus-based vector","volume":"95","author":"Chao","year":"2000","journal-title":"Blood."},{"key":"10.1006\/mthe.2001.0449_bib31","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1055\/s-0037-1614405","article-title":"Endogenous canine FIX antigen exists in Chapel Hill strain hemophilia B canine","volume":"82","author":"Chao","year":"1999","journal-title":"Thromb. Haemost."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001601904496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001601904496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T19:07:59Z","timestamp":1583953679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001601904496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S1525001601904496"],"URL":"https:\/\/doi.org\/10.1006\/mthe.2001.0449","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}